
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Allgemeine Reserven 2011-2026 | QTNT
Allgemeine Reserven Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 M | 20.5 M | 15.6 M | 16.3 M | 13.6 M | 12.6 M | 4.61 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22 M | 4.61 M | 15 M |
Allgemeine Reserven Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 12.8 M | 22.1 M | 22 M | 22.8 M | 25 M | 23.2 M | 23.2 M | 23.7 M | 23.7 M | 22.8 M | 21.3 M | 19.8 M | 18.1 M | 16.7 M | 15.6 M | 15.3 M | 15.3 M | 15.6 M | 16.3 M | 16.5 M | 15.2 M | 14.8 M | 13.6 M | 13.2 M | 13.4 M | 12.8 M | 12.6 M | 7.81 M | 5.83 M | 5.01 M | 4.61 M | 4.59 M | 4.42 M | 4.64 M | 4.56 M | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25 M | 4.42 M | 15.1 M |
Allgemeine Reserven anderer Aktien in der Diagnostik & Forschung
| Name | Allgemeine Reserven | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
830 M | $ 118.3 | 0.66 % | $ 36 B | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 20.92 | 1.06 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
992 K | $ 1.62 | 1.89 % | $ 2.15 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 24.62 | 0.08 % | $ 684 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 181.35 | -2.18 % | $ 8.99 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 4.17 | -17.1 % | $ 386 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.93 | 0.79 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
35.4 M | $ 215.74 | 4.34 % | $ 21.2 B | ||
|
Guardant Health
GH
|
85.9 M | $ 91.76 | 2.5 % | $ 11.5 B | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
15 M | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 124.55 | 2.66 % | $ 10.3 B | ||
|
Illumina
ILMN
|
547 M | $ 142.45 | 2.43 % | $ 22.6 B | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 2.11 | 5.09 % | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 473.47 | 1.44 % | $ 178 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.17 | -0.69 % | $ 4.98 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 257.95 | 0.32 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 59.72 | 5.33 % | $ 3.57 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.16 | -1.19 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 188.65 | -1.15 % | $ 20.9 B | ||
|
Waters Corporation
WAT
|
572 M | $ 348.15 | 1.58 % | $ 20.7 B |